Evaluation of safety of insulin degludec on undergoing total colonoscopy using continuous glucose monitoring

Journal of Diabetes Investigation

Volumn 7, Issue 3, 2016, Pages 374-380

  Takeishi, Soichi ^a   Mori, Akihiro ^a   Fushimi, Nobutoshi ^a   Hachiya, Hiroki ^a   Yumura, Takayuki ^a   Ito, Shun ^a   Shibuya, Takashi ^a   Ohashi, Noritsugu ^a   Kawai, Hiromi ^a  

^a Ichinomiya Nishi Hospital   (Japan)

Author keywords

Continuous glucose monitoring; Insulin degludec; Total colonoscopy

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN DEGLUDEC; INSULIN GLARGINE; SULFONYLUREA; THIAZOLIDINE DERIVATIVE; LONG ACTING INSULIN;

AGED; ANTIDIABETIC ACTIVITY; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; COLONOSCOPY; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADVERSE EFFECTS; DIABETES MELLITUS, TYPE 2; EVALUATION STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGIC MONITORING; PROCEDURES;

AGED; COLONOSCOPY; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE; HUMANS; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC;

EID: 84964927969     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12409     Document Type: Article

References (15)

1. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97: 1679-1687.
2. Atkin W, Dadswell E, Wooldrage K, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet 2013; 381: 1194-1202.
3. Heise T, Hermanski L, Nosek L, et al. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes Metab 2005; 14: 859-864.
4. Soichi T, Nobutoshi F, Takashi S, et al. Comparison of insulin degludec vs. insulin glargine using continuous glucose monitoring (CGM): Crossover study (in Japanese with English abstact). J Jpn Diab Soc 2014; 57: 321-328.
5. Heise T, Nosek L, Coester HV, et al. Steady state is reached within two to three days of once-daily administration of ultra- long-acting insulin degludec. Diabetes 2012; 61(Suppl 1): A259.
6. Nishimura R, Tsujino D, Taki K, et al. Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -Results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study. Cardiovasc Diabetol 2010; 9: 16: 1-5.
7. Rodbard D. New and improved methods to characterize glycemic variability using continuous glucose monitoring. Diabetes Technol Ther 2009; 11: 551-565.
8. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial. Diabetes Care 2010; 33: 17-22.
9. Jonassen I, Havelund S, Hoeg-Jensen T, et al. Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin. Pharm Res 2012; 29: 2104-2114.
10. Peacock I, Tattersall RB. The difficult choice of treatment for poorly controlled maturity onset diabetes tablets or insulin? Br Med J (Clin Res Ed) 1984; 288(6435): 1956-1959.
11. El-Serag HB, Tran T, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
12. Matsuo M. Association between diabetes mellitus and hepatocellular carcinoma: results of a hospital-and community-based case-control study. Kurume Med J 2003; 50: 91-98.
13. Latchford A, Greemhalf W, Vitone LJ, et al. Peutz-Jeghers syndrome and screening for pancreatic cancer. Br J Surg 2006; 93: 1446-1455.
14. Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer. Arch Intern Med 2006; 166: 1871-1877.
15. Kitabchi AE, Umpierrez GE, Miles JM, et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32: 1335-1343.